Welcome to our dedicated page for National Health Investors news (Ticker: NHI), a resource for investors and traders seeking the latest updates and insights on National Health Investors stock.
National Health Investors, Inc. (NHI) provides essential updates for stakeholders tracking this healthcare-focused REIT. This page aggregates official announcements and strategic developments related to senior housing financing, medical facility transactions, and operational partnerships.
Investors and analysts will find timely updates on earnings reports, property acquisitions, and joint venture formations, along with regulatory filings and dividend declarations. The curated news flow emphasizes NHI's core activities in sale-leaseback transactions and specialty hospital financing.
Bookmark this page to monitor NHI's progress in capitalizing on aging population trends through its diversified portfolio of assisted living communities, memory care facilities, and skilled nursing properties. Check regularly for insights into how the company balances stable rental income with growth-oriented mezzanine financing strategies.
National Health Investors, Inc. (NHI) filed a supplemental proxy statement with the SEC detailing steps taken by the Board of Directors in response to stockholders' concerns. The Board plans to propose amending the Articles of Incorporation, search for a new director, and evaluate Board composition.
National Health Investors, Inc. (NYSE:NHI) will pay a second quarter dividend of $0.90 per common share on August 2, 2024, to stockholders of record as of June 28, 2024.
National Health Investors, Inc. (NYSE:NHI) has issued an investor update focusing on their real estate investments in senior housing and medical facilities. NHI's diverse portfolio includes various types of healthcare properties. For more details, visit their website.
National Health Investors, Inc. (NYSE:NHI) announced its Q1 2024 results, showing net income per share of $0.71, NAREIT FFO per share of $1.10, and Normalized FFO per share of $1.12. The company updated its 2024 annual guidance and reported various financial figures. NHI's CEO highlighted deferral repayments, revenue growth, and raised guidance for the full year, emphasizing internal growth potential and financial strength.